Found 8 matching trials
Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities N/A Although antibody-drug conjugate(ADC) has proved effective in treating many...
Show More Location
Central South University
Learn More & Join Trial
Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy PHASE1 In this combined phase I/II, open label, single arm trial to study, the saf...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA) N/A Antineoplastic and immunomodulating agents may lead to various cardio-vascu...
Show More Location
AP-HP, Pitié-Salpêtrière Hospital,Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM.
Learn More & Join Trial
Chart Review Study to Describe the Clinical Profile of Idiopathic Pulmonary Fibrosis (IPF) Patients Treated With Nintedanib (OFEV®) in Real-world Practice in Spain N/A The present study has been designed to characterize IPF patients treated wi...
Show More Location
Dynamic solutions
Learn More & Join Trial
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent PHASE1 This clinical trial is designed as a multi-center, open-label, dose-escalat...
Show More Location
CHA University Bundang Medical Center
Learn More & Join Trial
Evaluation of Reporting of AdVerse Events Associated With AnTicAncer theRapy (AVATAR) N/A Anticancer drugs can lead to various adverse events. This study analyses re...
Show More Location
Alexandre Joachim
Learn More & Join Trial
Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19. PHASE3 To evaluate the efficacy of subcutaneous ropeginterferon alfa 2b ( P1101com...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy PHASE4 Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) is a mainstay for treating hea...
Show More Location
Assistance Publique Hôpitaux de Marseille
Learn More & Join Trial